The effects of homologous plasma HDL and VHDL fractions on established atherosclerotic lesions were studied in cholesterol-fed rabbits. Atherosclerosis was induced by feeding the animals a 0.5% cholesterol-rich diet for 60 d (group 1). Another group of animals were maintained on the same diet for 90 d (group 2). A third group was also fed the same diet for 90 d but received 50 mg HDL-VHDL protein per wk (isolated from normolipemic rabbit plasma) during the last 30 d (group 3). Aortic atherosclerotic involvement at the completion of the study was 34±4% in group 1, 38.8±5% in group 2, and 17.8±4% in group 3 (P < 0.005). Aortic lipid deposition was also significantly reduced in group 3 compared with group 1 (studied at only 60 d) and group 2. This is the first in vivo, prospective evidence of the antiatherogenic effect of HDL-VHDL against preexisting atherosclerosis. Our results showed that HDL plasma fractions were able to induce regression of established aortic fatty streaks and lipid deposits. Our results suggest that it may be possible not only to inhibit progression but even to reduce established atherosclerotic lesions by HDL administration. (J. Clin. Invest. 1990.
Introduction
The most important characteristic of atherosclerotic arteries is the accumulation of cholesterol within the vessel wall as a consequence of an unbalanced cholesterol influx-efflux. "Reverse cholesterol transport" seems to be the major route for removal of the exchangeable cholesterol deposited in tissues that do not metabolize it, and for its transport to the liver and subsequent metabolization (1, 2) . The concept of a reverse cholesterol transport pathway, with the HDL particle serving as scavenger of tissue cholesterol, has been enthusiastically accepted since it was postulated by Glomset more than 20 yr ago (3) .
The role of plasma HDL as the preferential physiological acceptor for cholesterol from extrahepatic cells in vivo has been strongly supported by epidemiologic and in vitro studies (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . Furthermore, we have reported that homologous HDL plasma fraction (d = 1.063-1.25 g/ml) inhibits the develop- group 1, a randomly selected group of 10 animals, were killed and the aortic fatty streak formation and cholesterol deposition were studied. This group provided the baseline for atherosclerotic lesions obtained before the HDL-VHDL or saline administration. Groups 2 (n = 7) and 3 (n = 7) were studied after 30 more days on the atherogenic diet. During this period, group 3 received the HDL-VHDL plasma fraction, while group [30 DAYS] i Plasma lipid analysis. Blood samples were collected in EDTA (1.5 mg/ml). All the animals were tested for their baseline and killing levels of total and HDL-cholesterol and triglycerides after 12-16 h fasting. Plasma was immediately obtained by low speed centrifugation at 4VC.
Aliquots were separated and kept frozen at -70'C until assayed. Cholesterol content was determined using an enzymatic kit (Dry Stat; Beckman Instruments, Inc., Carlsbad, CA). Triglyceride content of plasma was measured using an enzymatic kit (Seragen Diagnostics Inc., Indianapolis, IN) as previously described (18, 19) . HDL-cholesterol was measured in plasma after precipitation of apo B-containing lipoproteins by PEG-6000 (29), as we have described (18, 19) . The HDL-cholesterol was isolated in an aliquot of fresh plasma and thereafter kept frozen until assayed.
Biochemical analysis of aortic wall and liver. Aortas (half) were homogenized at 4VC in 5 ml of0.13 M Tris HCO (pH 7.4), 0.01% NaN3 using a homogenizer (Polytron Corp., Elkhart, IN). The total lipids were extracted from the homogenates in 10 vol of chloroform/methanol (2:1; vol/vol) containing 0.001% butylated hydroxytoluene (2,5- Di-t-butyl-p-cresol 4-methyl-2,6-test-butylphenol) as an antioxidant. A second extraction with the Folch procedure was then carried out (30) .
The lipid-containing fraction was dried under nitrogen and then resuspended in isopropyl alcohol (31) . The triglycerides, total cholesterol, and free cholesterol levels were measured by the specific enzymatic assays mentioned for plasma lipid analysis; esterified cholesterol was calculated as the difference between total and free cholesterol. Phospholipid determinations were performed using an enzymatic kit (Wako Pure Chemical Industries, Ltd.).
The same procedure was followed with the livers. Livers were homogenized, and total cholesterol levels measured in the lipid extracts (31) by using a specific enzymatic assay (Dry Stat; Beckman Instruments, Inc.).
Hematological analysis and animal surveillance. Platelet number, size, and distribution were determined with a P260 platelet analyzer (Coulter Electronics Inc., Hialeah, FL) as we have reported (32) . Rab (Table I ). The so-called "atherogenic" lipoproteins (VLDL and LDL; d < 1.063 g/ml) accounted for more than 95% of the total cholesterol. All groups showed a marked decrease in the choles- The aortic atherosclerotic involvement was evaluated by computerized planimetry of the Sudan IV-positive areas, expressing the results as a percentage of the total aortic surface covered by fatty lesion (Fig. 4) fatty streaks, a statistically significant difference (P < 0.005) not only compared with group 2 (90 d on diet), but also when compared even with group 1 (60 d on diet) (P < 0.005).
Histological examination of the aortas of the three groups of animals revealed similar lesions characterized by accumulation oflipids in the hyperplastic areas ofthe inner layer ofthe intima (Fig. 5) . A decrease in lesion thickness in the group 3 (HDL-VHDL) animals (Fig. 5 A) is evident in comparison with the animals in groups 1 and 2 (Fig. 5, B Group 2 (90 d on diet) showed heavier lipid deposition in the aortic wall than group 1 (atherosclerosis-induction 60 d on diet), probably due to the longer time on the diet. Group 3 (HDL-treated) had a 55% reduction of total cholesterol (P < 0.05), 59% reduction ofesterified cholesterol (P < 0.05), and 59% reduction of phospholipids (P < 0.05) with no differences in free cholesterol and triglycerides when compared with group 2. When group 3 was compared with group 1 (only 60 d on atherogenic diet) significant decreases in total cholesterol (P < 0.05), free cholesterol (P < 0.05), and phospholipids (P < 0.05) were also observed (Fig. 6) .
Cholesterol accumulation in the liver. The total cholesterol content in the livers is presented in Fig. 7 . HDL-VHDL treatment (group 3) showed a trend toward lesser cholesterol accumulation in the livers even though it did not reach statistical significance.
Effect of diet and treatment. All groups had similar body weight gain throughout the experimental period. The HDL-VHDL-treated rabbits gained an average of 0.85±0.4 kg (range 0.5-1.0 kg), and group 2 gained an average of 0.7±0.2 kg (ranging from 0.4 to 0.8 kg). No difference in food intake was observed among groups. Hematocrit, platelet, and red blood cell counts were similar in all groups. The animals showed good physical appearance and normal behavior during the entire experiment.
Discussion
In a previous study we have shown that homologous HDL-VHDL administered concomitantly with an atherogenic diet inhibits aortic fatty streak formation and cholesterol deposition in cholesterol-fed rabbits (18) . The present study sought to determine if homologous HDL-VHDL administration, after atherosclerotic lesions have been established, could inhibit or reverse its further development. After the high-cholesterol diet was given for 60 d, the animals had 34% of their aortic surface covered by fatty streaks containing 15±2.4 mg of cholesterol/g of aorta. These values match those of previous studies using the same dietary method of atherosclerosis induction (18, 19) . The remaining animals ofthe study were kept on the same diet for 30 more days with one group (group 3), being given 50 mg/wk of homologous HDL-VHDL protein and the other (group 2) given saline solution as control.
Our results showed that administration of homologous HDL-VHDL not only inhibited the progression of established atherosclerotic lesions, when compared with group 2 (90 d on diet), but also induced significant regression of aortic fatty streaks and cholesterol deposition when compared with group 1 (atherosclerosis-induction group, 60 d on diet). Therefore, HDL-VHDL have been shown to reverse the extent of arterial damage and lipid infiltration induced by 90 d of an atherogenic diet to levels significantly lower than those achieved after 60 d on the diet. HDL-treated animals (group 3) developed 54% less aortic infiltration with fatty streaks, as determined by computerized planimetry of the aortic wall, than the control animals (group 2). Their aortas also contained 56.3% less cholesterol than those of controls.
An abundance of data confirming the inverse relationship between HDL and arterial atherosclerotic disease have been reported (4-9). To date, such studies have been retrospective, and no prospective interventional studies other than ours (18) have been conducted to test the efficacy of HDL in preventing or inhibiting the development of atherosclerotic disease. Studies in tissue culture systems have lent credence to the hypothesis that HDL protects against the development of atherosclerosis (10) (11) (12) (13) (14) (15) (16) (17) . Such studies have indicated that HDL may exert this beneficial effect by facilitating reverse cholesterol transport, namely, transporting cholesterol away from extra-hepatic tissues and carrying it back to the liver where it can be eliminated (14) (15) (16) .
Using in vitro systems, other authors have reported that not only HDL, but also VHDL, may exert an antiatherogenic effect (14, 16, 33) . For example, plasma proteins obtained in the d > 1.21 g/ml fraction can remove cholesterol from macrophages (14, 33) , while albumin and 7y-globulins, the two major proteins of this fraction, did not accept large amounts of cholesterol (14) . In our experimental protocol, we used the plasma fraction obtained at density range 1.063-1.25 g/ml, which contains HDL2 (d = 1.063-1.12 g/ml) HDL3 (d = 1.12-1.21 g/ml), and VHDL (d = 1.21-1.25 g/ml). In addition, it has been reported that this density fraction includes the lipid transfer proteins which have been shown to enhance transfer and exchange of lipids between lipoproteins in plasma (23) (24) (25) (26) (27) . The dosage and frequency ofthe lipoprotein administration (50 mg protein content given intravenously once a week), is the same that successfully inhibited the development of fatty streak and lipid accumulation in the aortic wall in our earlier study ( 18) .
In the present study, as expected, all the animals rapidly (36) , polyunsaturated oils (37), and probucol (38, 39) . It has also been reported that intravenous administration of large amounts of dispersed phospholipids (0.5-3.5 g two to three times a week) induces regression of experimental atherosclerosis in rabbits (39) (40) (41) .
In a preliminary study, we reported that HDL stimulated prostacyclin (PGI2) synthesis by aortic wall in normal (42) and atherosclerotic rabbits (43). It has been reported that prostaglandins modulate arterial cholesteryl-ester metabolism by stimulating the enzyme cholesteryl-hydrolase (44) . Therefore, an increased prostacyclin production in the HDL-treated group might also account for the observed antiatherogenic effect.
It has also been shown that HDL reverses the accumulation of cholesteryl esters by continuous hydrolysis and reesterification in macrophage-like cell lines (45) .
Of interest is the observation that the HDL-VHDL-treated group (group 3) presented a lesser extent of aortic fatty streaks (Sudan IV-positive areas) than did group 1 (atherosclerosisinduction group) (Fig. 4) . A similar finding was observed when analyzing the lipid accumulation within aortic wall (Fig. 6) . HDL-VHDL treatment not only significantly inhibited aortic lipid deposition when compared with group 2, but also yielded a significantly lower lipid accumulation than in group 1. Inasmuch as all the animals had similar levels of plasma cholesterol available for deposition within vessel wall, our results strongly support the hypothesis that homologous HDL-VHDL administration stimulates reverse cholesterol transport from Atherosclerosis Regression by High Density Lipoproteins 1239 Our results parallel findings obtained in tissue culture experiments (10) (11) (12) (13) (14) (15) (16) (17) and support for the first time in vivo, the hypothesis that HDLs have an antiatherogenic effect. Such antiatherogenic effect may be mediated through the postulated role of HDL in reverse cholesterol transport, even though no conclusive proof could be obtained from our study and more studies are needed. Regression of atherosclerotic lesions has been reported by different interventions in animal models (see references [46] [47] [48] and recently in human studies (49) , suggesting that a mechanism may exist for removing the cholesterol accumulated in the vessel wall. The current report is the first prospective in vivo evidence of the inhibitory effect of HDL in established atherosclerosis.
In conclusion, our results suggest that it may be possible to diminish the progression and even reverse already established atherosclerotic lesions by administration of HDL-VHDL.
